Mechanisms of enhanced osteoclastogenesis in girls and young women with Turner's Syndrome

被引:28
作者
Faienza, Maria Felicia [1 ]
Brunetti, Giacomina [2 ]
Ventura, Annamaria [1 ]
Piacente, Laura [1 ]
Messina, Maria Francesca [3 ]
De Luca, Filippo [3 ]
Ciccarelli, Maria [1 ]
Oranger, Angela [2 ]
Mori, Giorgio [4 ]
Natale, Maria Pia [1 ]
Gigante, Margherita [5 ]
Ranieri, Elena [6 ]
Gesualdo, Loreto [5 ]
Colucci, Silvia [2 ]
Cavallo, Luciano [1 ]
Grano, Maria [2 ]
机构
[1] Univ Aldo Moro Bari, Dept Biomed Sci & Human Oncol, Pediat Sect, I-70124 Bari, Italy
[2] Univ A Moro Bari, Dept Basic Med Sci Neurosci & Sense Organs, Sect Human Anat & Histol, I-70124 Bari, Italy
[3] Univ Messina, Dept Pediat Gynecol Microbiol & Biomed Sci, Messina, Italy
[4] Univ Foggia, Dept Clin & Expt Med, Foggia, Italy
[5] Univ A Moro Bari, Dept Emergency & Organ Transplantat, Nephrol Dialysis & Transplantat Unit, I-70124 Bari, Italy
[6] Univ Foggia, Dept Med & Surg Sci, Clin Pathol, Foggia, Italy
关键词
Turner's syndrome; Osteoclastogenesis; FSH; RANKL; T cells; BONE-MINERAL DENSITY; CELLS SUPPORT OSTEOCLASTOGENESIS; ESTROGEN REPLACEMENT THERAPY; GROWTH-HORMONE THERAPY; LOW-DOSE ESTROGEN; KAPPA-B LIGAND; RECEPTOR ACTIVATOR; RANKL; DEFICIENCY; PUBERTY;
D O I
10.1016/j.bone.2015.07.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Subjects with hypergonadotropic hypogonadism due to Turner's syndrome show low cortical mineral density, osteoporosis and risk of fractures. It is not clear if this bone fragility derives from chromosomal abnormalities or is the result of inadequate bone formation due to estrogen deficiency. The aim of this study was to investigate the cellular mechanisms underlying bone fragility in subjects with Turner's syndrome before induction of puberty and after hormonal replacement therapy (HRT). For this purpose, we have evaluated the osteoclastogenic potential of non-fractioned and T-cell depleted cultures of peripheral blood mononuclear cells (PBMCs) belonging to girls with Turner's syndrome who had not been treated with HRT yet, girls and young women who were on HRT and age-matched controls. Untreated subjects showed high FSH serum levels, whereas the other subjects displayed normal FSH serum levels. T-cell immunophenotype was analyzed through flow cytometry. Biochemical and DXA analyses were performed. Spontaneous osteoclastogenesis in non-fractioned and T-cell depleted cultures of PBMC belonging to girls with high FSH levels was more evident than in cultures of subjects with normal FSH levels. In the former, osteoclastogenesis was sustained by monocytes expressing high levels of c-fms, TNF-alpha and RANK, and T-cells producing high RANKL and TNF-alpha; in the latter it was supported by T-cells expressing high RANKL levels. CD4(+)CD25(high) T-cells were reduced in all subjects, whereas CD3(+)/CD16(+)/CD56(+) NKT-cells were increased in those with high FSH levels. High RANKL and CTX levels were detected in the sera. Bone impairment was already detectable by DXA in subjects aged under 10, although it became more evident with aging. In conclusion, our results demonstrated that bone fragility in subjects with Turner's syndrome is associated to enhanced osteoclastogenesis. This process seems to be due to high FSH serum levels before HRT, whereas it is caused by high RANKL during HRT. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:228 / 236
页数:9
相关论文
共 45 条
  • [1] Growth hormone therapy and bone mineral density in Turner syndrome
    Bakalov, VK
    Van, PL
    Baron, J
    Reynolds, JC
    Bondy, CA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (10) : 4886 - 4889
  • [2] Selective reduction in cortical bone mineral density in Turner syndrome independent of ovarian hormone deficiency
    Bakalov, VK
    Axelrod, L
    Baron, J
    Hanton, L
    Nelson, LM
    Reynolds, JC
    Hill, S
    Troendle, J
    Bondy, CA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (12) : 5717 - 5722
  • [3] Fracture risk and bone mineral density in Turner syndrome
    Bakalov, Vladimir K.
    Bondy, Carolyn A.
    [J]. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2008, 9 (02) : 145 - 151
  • [4] Clinical practice guideline - Care of girls and women with Turner syndrome: A guideline of the Turner Syndrome Study Group
    Bondy, Carolyn A.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (01) : 10 - 25
  • [5] Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases:: implications of their relative ratio
    Bostanci, Nagihan
    Ilgenli, Tunc
    Emingil, Guelnur
    Afacan, Beral
    Han, Buket
    Toez, Hueseyin
    Atilla, Guel
    Hughes, Francis J.
    Belibasakis, Georgios N.
    [J]. JOURNAL OF CLINICAL PERIODONTOLOGY, 2007, 34 (05) : 370 - 376
  • [6] T cells support osteoclastogenesis in an in vitro model derived prom human periodontitis patients
    Brunetti, G
    Colucci, S
    Pignataro, P
    Coricciati, M
    Mori, G
    Cirulli, N
    Zallone, A
    Grassi, FR
    Grano, M
    [J]. JOURNAL OF PERIODONTOLOGY, 2005, 76 (10) : 1675 - 1680
  • [7] Follicle-stimulating hormone promotes RANK expression on human monocytes
    Cannon, Joseph G.
    Kraj, Barbara
    Sloan, Gloria
    [J]. CYTOKINE, 2011, 53 (02) : 141 - 144
  • [8] T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction
    Colucci, S
    Brunetti, G
    Rizzi, R
    Zonno, A
    Mori, G
    Colaianni, G
    Del Prete, D
    Faccio, R
    Liso, A
    Capalbo, S
    Liso, V
    Zallone, A
    Grano, M
    [J]. BLOOD, 2004, 104 (12) : 3722 - 3730
  • [9] Spontaneous osteoclast formation from peripheral blood mononuclear cells in postmenopausal osteoporosis
    D'Amelio, P
    Grimaldi, A
    Pescarmona, GP
    Tamone, C
    Roato, I
    Isaia, G
    [J]. FASEB JOURNAL, 2004, 18 (15) : 410 - +
  • [10] Osteoporosis in Turner's syndrome and other forms of primary amenorrhoea
    Davies, MC
    Gulekli, B
    Jacobs, HS
    [J]. CLINICAL ENDOCRINOLOGY, 1995, 43 (06) : 741 - 746